Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 28 February 2012
Vol. 5, Issue 213, p. ra18
[DOI: 10.1126/scisignal.2002138]


Editor's Summary

Self-Directed Phosphatase
The lipid and protein phosphatase PTEN, which acts as a tumor suppressor, is known for its ability to dephosphorylate phosphatidylinositol 3,4,5-trisphosphate and thereby antagonize mitogenic signaling by phosphoinositide 3-kinase and downstream effectors, such as AKT. The role of PTEN’s protein phosphatase activity, however, is less clear. Tibarewal et al. used PTEN mutants to isolate its protein phosphatase activity from its lipid phosphatase activity and found that both appeared to be required on the same molecule for PTEN to inhibit glioma cell invasion in vitro. In addition, both its lipid and its protein phosphatase activities were required to mediate many of PTEN’s largest effects on gene expression. Various lines of evidence indicated that PTEN dephosphorylated a residue in its own C-terminal tail and implicated dephosphorylation of this residue in limiting invasion independently of any effects on AKT, leading the authors to propose that autodephosphorylation may enable targeting PTEN’s lipid phosphatase activity to a particular locale. The authors identified a PTEN mutant from a human lung cancer cell line that retained the ability to decrease AKT’s phosphorylation and catalytic activity but lacked protein phosphatase activity and failed to suppress invasion, suggesting that PTEN’s protein phosphatase activity may contribute to its tumor suppressor function.

Citation: P. Tibarewal, G. Zilidis, L. Spinelli, N. Schurch, H. Maccario, A. Gray, N. M. Perera, L. Davidson, G. J. Barton, N. R. Leslie, PTEN Protein Phosphatase Activity Correlates with Control of Gene Expression and Invasion, a Tumor-Suppressing Phenotype, But Not with AKT Activity. Sci. Signal. 5, ra18 (2012).

Read the Full Text

Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240.
T. R. Fenton, D. Nathanson, C. Ponte de Albuquerque, D. Kuga, A. Iwanami, J. Dang, H. Yang, K. Tanaka, S. M. Oba-Shinjo, M. Uno, et al. (2012)
PNAS 109, 14164-14169
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882